compound
CJC-1295 DAC (2mg Vial) Questions Answered
CJC-1295 DAC is a long-acting synthetic analog of growth hormone-releasing hormone (GHRH).
CJC-1295 DAC (2mg Vial)
Week Per-Injection Dose (mcg) Units (per injection) (mL) Weekly Total Weeks 1–2 300 mcg (0.3 mg) 30 units (0.30 mL) 600 mcg/week Weeks 3–4 500 mcg (0.5 mg) 50 units (0.50 mL) 1000 mcg/week Weeks 5–6 750 mcg (0.75 mg) 75 units (0.75 mL) 1500 mcg/week Weeks 7...
CJC-1295 DAC is a long-acting synthetic analog of growth hormone-releasing hormone (GHRH).
Week Per-Injection Dose (mcg) Units (per injection) (mL) Weekly Total Weeks 1–2 300 mcg (0.3 mg) 30 units (0.30 mL) 600 mcg/week Weeks 3–4 500 mcg (0.5 mg) 50 units (0.50 mL) 1000 mcg/week Weeks 5–6 750 mcg (0.75 mg) 75 units (0.75 mL) 1500 mcg/week Weeks 7...
Plan based on an 8–16 week twice-weekly protocol with gradual titration. Peptide Vials (CJC-1295 DAC, 2 mg each): 8 weeks ≈ 6 vials 12 weeks ≈ 10 vials 16 weeks ≈ 14 vials Insulin Syringes (U-100): Per week: 2 syringes (twice weekly) 8 weeks: 16 syringes 12...
Practical considerations for consistency and safety. Use new sterile insulin syringes; dispose in a sharps container.